Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600273 · ClinicalTrials.gov registry record · NA
Novel Approaches to Reducing Tobacco Related Harm
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02600273: Completed NA study, sponsored by Duke University.
NCT02600273 is a NA study that has completed, run by Duke University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600273, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.
Primary Outcome
Satisfaction, acceptability, withdrawal, craving
Interventions
- OTHER Usual brand cigarettes
- OTHER Lower nicotine content cigarettes
- OTHER Electronic cigarettes 1
- OTHER Electronic cigarettes 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-06 |
| Phase | NA |
What the finished NCT02600273 record still lists
NCT02600273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Usual brand cigarettes is the first listed.
NCT02600273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02600273 about?
NCT02600273 is a clinical study titled "Novel Approaches to Reducing Tobacco Related Harm". The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.
What is the current status of trial NCT02600273?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-01. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02600273?
The interventions under investigation include: Usual brand cigarettes (OTHER), Lower nicotine content cigarettes (OTHER), Electronic cigarettes 1 (OTHER), Electronic cigarettes 2 (OTHER).
Who is sponsoring clinical trial NCT02600273?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02600273's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia